Upon engagement by its ligand HLA-C, CD160 can trigger robust NK cell activation leading to efficient tumor cell lysis (135) and secretion of TNF-α, IFN-γ, and IL-6 (136, 137), making it a potential target for NKCE development. This evidence concerns the gene IFNG and neoplasm.